Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

37.66 -1.80 (-4.55%)

Streaming Delayed Price Updated: 3:35 PM EST, Dec 18, 2025 Add to My Watchlist

Price and Volume

Volume	1,683,122
Open	39.49
Bid (Size)	37.64 (400)
Ask (Size)	37.67 (400)
Prev. Close	39.45
Today's Range	37.23 - 40.04
52wk Range	3.720 - 43.73
Shares Outstanding	85,465,249
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

A late-stage biotech with three pivotal trials underway just landed a major hedge-fund backer — here’s why the timing matters.

Via The Motley Fool

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Amylyx Stock is up a staggering 166% over the past year, and this biotech-focused hedge fund is still doubling down.

Via The Motley Fool

Performance

YTD	+382.8%	+382.8%
1 Month	+11.6%	+11.6%
3 Month	+204.7%	+204.7%
6 Month	+420.1%	+420.1%
1 Year	+359.8%	+359.8%

More News

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

Via The Motley Fool

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗

December 03, 2025

Via The Motley Fool

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗

December 03, 2025

Via The Motley Fool

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

Via The Motley Fool

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session. ↗

November 10, 2025

Via Chartmill

Top movers in Monday's session ↗

November 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Gold Jumps Over 2%; Dole Shares Gain After Q3 Results ↗

November 10, 2025

Via Benzinga

Cogent Biosciences Hits 7-Year High, Up 120% On Its New Stomach Cancer Promise ↗

November 10, 2025

Via Investor's Business Daily

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 10, 2025

Via Chartmill

Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial ↗

November 10, 2025

Via Benzinga

Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday ↗

November 10, 2025

Via Benzinga

S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings ↗

November 10, 2025

Via Benzinga

Monday's pre-market session: top gainers and losers ↗

November 10, 2025

Via Chartmill

Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results

October 13, 2025

Via MarketMinute

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday ↗

September 03, 2025

Via Benzinga

3 Stocks With Sky-High Overbought Signals: QuantumScape, Opendoor, Cogent Flash RSI Red Flags ↗

July 21, 2025

Via Benzinga

Cogent Biosciences Scores Analyst Praise As Mastocytosis Drug Hits Trial Goals; Retail Buzz Surges ↗

July 08, 2025

Via Stocktwits

Frequently Asked Questions

Is Cogent Biosciences, Inc. - Common Stock publicly traded?

Yes, Cogent Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Cogent Biosciences, Inc. - Common Stock trade on?

Cogent Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cogent Biosciences, Inc. - Common Stock?

The ticker symbol for Cogent Biosciences, Inc. - Common Stock is COGT on the Nasdaq Stock Market

What is the current price of Cogent Biosciences, Inc. - Common Stock?

The current price of Cogent Biosciences, Inc. - Common Stock is 37.66

When was Cogent Biosciences, Inc. - Common Stock last traded?

The last trade of Cogent Biosciences, Inc. - Common Stock was at 12/18/25 03:35 PM ET

What is the market capitalization of Cogent Biosciences, Inc. - Common Stock?

The market capitalization of Cogent Biosciences, Inc. - Common Stock is 3.22B

How many shares of Cogent Biosciences, Inc. - Common Stock are outstanding?

Cogent Biosciences, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.